Getting 'real' with real-world data: Discussing benefits & challenges of RWD in clinical trials
Wednesday, September 28, 2022
11:30 AM - 1:00 PM
Add to Calendar
Central Standard Time
Join executive leaders from Walgreens, AbbVie, Cardinal, and Foley Partners as they discuss how their organizations are using real-world evidence (RWE) to move the needle on clinical trials to improve access to medications.
Today, clinical research, and the data collected within it, need to be more reflective of the real-world settings in which patients live, so that providers can better close care gaps and improve outcomes. As such, RWE is playing an increasing role in healthcare and regulatory decision making, especially as the US Food and Drug Administration (FDA) is more open to accepting RWE to support its assessment of medical products. However, RWE stakeholders lack a shared understanding of the FDA’s expectations for the use of RWE in applications and research for new drugs and biologics.
As the healthcare and life sciences industry further develops common standards, structures and processes around RWE generation, consideration must be made to use cases that support the FDA's recent steps to increase racial and ethnic diversity in clinical trials.